Skip to content

Basophil degranulation assay as an in vitro model of anaphylaxis

Basophil degranulation assay as an in vitro model of anaphylaxis - BDA

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON38967
Enrollment
35
Registered
2013-08-14
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hymenoptera venom allergy insect venom allergy

Interventions

None listed

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - A clear positive history of a systemic response grade IV or a large local reaction after a vespid sting* - Vespid specific serum IgE > 0.70 kUA/l or a positive intracutaneous skin test for vespid venom (at

Exclusion criteria

Exclusion criteria: - Age under 18 years - Incapacitated subjects - Conditions that influence the immune system (immune deficiencies, malignancy, auto-immune diseases) - Pregnancy (measured before inclusion by β-hCG) - Mastocytosis;Extra exclusion criteria for indicator subjects: - A positive history of a large local or systemic response after a Hymenoptera sting - Vespid specific serum IgE > 0.30 kUA/l

Design outcomes

Primary

MeasureTime frame
CD63 and CD203c expression on basophils.

Secondary

MeasureTime frame
Detection and comparison of factors in supernatant of basophils from anaphylactically sensitized patients compared to non-anaphylactically sensitized patients.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)